Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Follow-on investment. Round participant. Active |